Company acts to 'ensure the integrity of this critical step toward
personalized health care'
REDWOOD SHORES, Calif., April 8, 2008 /PRNewswire/ -- Navigenics, a personalized genetic health services company, today announced that it will develop a set of industry standards for consumer genomic testing services, and that it will seek broad, multi-stakeholder input and endorsement of these or similar criteria. Further, the company announced it will also support prospective health outcomes studies, involving leading medical centers and other partners, designed to examine the impact that consumer access to personal genetic information has on behaviors and health outcomes.
The Navigenics(TM) Health Compass service, officially launched today, uses genotyping, coupled with the latest research findings on genetic associations with an initial set of 18 common medical conditions, to provide a personalized genetic assessment to its members. The assessment comes with 24/7 access to a Genetic Counselor to help understand results, and is designed to be part of an ongoing process to help individuals and their professional health advisers apply the information to improve health. In addition, members have access to information on preventive measures and clinical research focused on avoiding or delaying the onset of these health conditions.
The company will present and solicit input on its proposed criteria from multiple stakeholders, among other subjects related to direct to consumer genetic testing, at a conference now being planned for later this year in collaboration with the Personalized Medicine Coalition.
"The Personalized Medicine Coalition looks forward to this conference
to explore key issues including the development of standards regarding
direct-to- consumer genetic testing," says Edward Abrahams, Ph.D.,
executive director of the Personalized Medicine Coalition. "This type of
service represents the public's firs
|SOURCE Navigenics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved